Both in Pharmaceuticals
Arcus Biosciences vs Biohaven
Over the past year RCUS returned −7.8% and BHVN returned −10.3%; their daily moves had a correlation of 0.32.
RCUS −7.8% BHVN −10.3%Growth of $1, one year, split-adjusted
| Metric | RCUS | BHVN |
|---|---|---|
| Price | $18.19 | $15.42 |
| Market cap | $2.32B | $2.33B |
| Today | −2.26% | −6.49% |
| 1 month | −27.9% | +17.4% |
| 6 months | −29.2% | +60.1% |
| Year to date | −23.7% | +36.6% |
| 1 year | −10.3% | −14.9% |
| Revenue growth (YoY) | −74.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −222.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 19.8× | — |
| Net cash | $601.0M | -$103.2M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 90.8% |
| Short % of float | 13.6% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).